Based on a year of strong growth, further validation of the core AI technologies and the recent acquisition of laboratory space, we are looking to expand our capabilities to support the company’s Drug Discovery activities. We are a fast-moving, user-centric company, working at the cutting edge of AI and scientific discovery.
We are keen to hear from Technical Product Managers who are excellent communicators, have a technical background, experience with AI and drug discovery, and a proven track record of working in an agile environment and cross-functional teams.
As a Technical Product Manager at BenevolentAI, you will play a hands-on role in driving forward our AI-driven products and processes, working with world-class engineers and scientists to understand data, derive technical and user requirements and translate them into valuable products. You will play a key role in the planning and refinement of sprints, managing cross-team dependencies within an Agile development environment, and you will be responsible for managing the product backlog.
Our tools are mainly cloud-based and use the very latest visualization and machine learning tools and techniques. You will need a solid understanding of the technical aspects of our tools and of the scientific domain. The ideal candidate will be comfortable and familiar with handling high-dimensional biological and/or chemical data. You will work closely with systems biologists and bioinformaticians to analyse and interpret the data to derive biological insights and testable hypotheses.
What will you be responsible for?
What skills, qualifications and experience do you need to be successful in this role?
BenevolentAI is applying artificial intelligence to develop new medicines for hard to treat diseases. It is the first fully integrated AI company with pharmaceutical discovery and clinical development capabilities. BenevolentAI’s technology aims to lowering cost, decrease failure rates and increasing the speed at which medicines are delivered to patients.
BenevolentAI currently employs 165 people who work in a unique, cross functional environment that incorporates leading edge data scientists, computer scientists, mathematicians and drug development R&D scientists working side by side. The company is headquartered in London with further offices in New York and Belgium. BenevolentAI’s research facility is located in Babraham Science Park, Cambridge (UK).
The company’s AI technology is being used to develop treatments to unmet patients’ needs across a wide range of diseases, including Motor Neuron Disease, Parkinson’s Disease, Glioblastoma and Sarcopenia.
The company offers a growing benefits package that includes pension, health insurance, a cycle-to-work scheme.